BioCentury
ARTICLE | Company News

EpiVax, Schroedinger deal

February 1, 2016 8:00 AM UTC

EpiVax and Schrodinger spun out virtual JV, Aceno Biotherapeutics, which will use computational tools to develop a portfolio of “biobetter” therapeutics that will be “immune-engineered” by EpiVax. Ac...